New CDC Publications
Lam CK, Fluegge K, Macaraig M, Burzynski J. Cost savings associated with video directly observed therapy for treatment of tuberculosis. Int J Tuberc Lung Dis 2019;23:1149–54.
Langer AJ, Navin TR, Winston CA, LoBue P. Epidemiology of tuberculosis in the United States. Clin Chest Med 2019;40:693–702.
Mase SR, Chorba T. Treatment of drug-resistant tuberculosis [Review]. Clin Chest Med 2019;40:775–95.
Menzies NA, Parriott A, Shrestha S, Dowdy DW, Cohen T, Salomon JA, Marks SM, Hill AN, Winston CA, Asay G, Barry P, Readhead A, Flood J, Kahn JG, Shete PB. Comparative modelling of tuberculosis epidemiology and policy outcomes in California. Am J Respir Crit Care Med 2019. Epub ahead of print.
Nahid P, Mase SR, Migliori GB, Sotgiu G, Bothamley GH, Brozek JL, Cattamanchi A, Cegielski JP, Chen L, Daley CL, Dalton TL, Duarte R, Fregonese F, Horsburgh CR Jr, Ahmad Khan F, Kheir F, Lan Z, Lardizabal A, Lauzardo M, Mangan JM, Marks SM, McKenna L, Menzies D, Mitnick CD, Nilsen DM, Parvez F, Peloquin CA, Raftery A, Schaaf HS, Shah NS, Starke JR, Wilson JW, Wortham JM, Chorba T, Seaworth B. Treatment of drug-resistant tuberculosis. An Official ATS/CDC/ERS/IDSA clinical practice guideline. Am J Respir Crit Care Med 2019;200:e93–142. (Parvez, also with the New York City Department of Health and Mental Hygiene).
No comments:
Post a Comment